CANT1 Antibody

Shipped with Ice Packs
In Stock

Description

Overview of CANT1 Antibody

CANT1 (Calcium-Activated Nucleotidase 1) antibodies are immunological tools designed to detect and study the CANT1 protein, a member of the apyrase family localized in the endoplasmic reticulum (ER) and Golgi apparatus. These antibodies enable researchers to investigate CANT1’s roles in proteoglycan biosynthesis, glycosylation, and skeletal development, as well as its implications in diseases such as Desbuquois dysplasia type 1 (DBQD1) and cancer .

Proteoglycan Biosynthesis and Skeletal Disorders

  • Role in DBQD1: Knock-out mouse models revealed CANT1’s critical role in glycosaminoglycan (GAG) chain synthesis and sulfation. Loss of CANT1 causes ER enlargement, delayed proteoglycan secretion, and growth plate defects, recapitulating DBQD1 phenotypes .

  • Mechanism: CANT1 hydrolyzes UDP, a byproduct of glycosyltransferase reactions, to regulate nucleotide levels in the ER/Golgi .

Cancer Research

  • Hepatocellular Carcinoma (HCC): CANT1 overexpression correlates with poor prognosis, advanced tumor stage, and immune cell infiltration (e.g., CD8+ T cells). It serves as an independent prognostic marker (AUC = 0.938) .

  • Retinoblastoma (RB): LncRNA CANT1 suppresses tumor progression by inhibiting PI3Kγ/Akt signaling. Overexpression reduces tumor growth in vitro and in vivo .

Technical Validation

  • Western Blot: Detected in LNCaP (prostate cancer), U2OS (osteosarcoma), and A549 (lung cancer) cell lines .

  • Subcellular Localization: Perinuclear staining in PC-3 prostate cancer cells .

Disease Associations

DiseaseCANT1 ExpressionClinical Impact
DBQD1Loss-of-functionSkeletal dysplasia, joint malformations
HCCOverexpressionPoor OS, advanced histologic grade
RetinoblastomaDownregulationEnhanced PI3K/Akt signaling, tumor growth

Therapeutic Potential

  • Targeting CANT1: Silencing CANT1 in renal cell carcinoma reduces proliferation and invasion .

Recommended Workflows

ApplicationDilutionSample Preparation
Western Blot1:500–1:5000Reduce lysates with β-mercaptoethanol
ICC/IF10 µg/mLFix cells with paraformaldehyde

Troubleshooting

  • Non-specific bands: Optimize blocking buffers (e.g., 5% BSA) and validate with knockout controls .

  • Low signal: Prolong antibody incubation (up to 3 hours at RT) .

Product Specs

Buffer
PBS with 0.02% Sodium Azide, 50% Glycerol, pH 7.3. Store at -20°C. Avoid repeated freeze-thaw cycles.
Lead Time
We typically dispatch orders within 1-3 business days of receiving them. Delivery times may vary depending on the purchasing method and location. For specific delivery information, please contact your local distributor.
Synonyms
Apyrase antibody; Apyrase homolog antibody; Ca2+ dependent endoplasmic reticulum nucleoside diphosphatase antibody; Calcium activated nucleotidase 1 antibody; CANT 1 antibody; CANT1 antibody; CANT1_HUMAN antibody; Putative MAPK activating protein PM09 antibody; Putative MAPK-activating protein PM09 antibody; Putative NF kappa B activating protein 107 antibody; Putative NF-kappa-B-activating protein 107 antibody; SCAN 1 antibody; SCAN-1 antibody; SHAPY antibody; Soluble Ca activated nucleotidase isozyme 1 antibody; Soluble calcium activated nucleotidase 1 antibody; Soluble calcium activated nucleotidase SCAN 1 antibody; Soluble calcium-activated nucleotidase 1 antibody
Target Names
CANT1
Uniprot No.

Target Background

Function
CANT1 is a calcium-dependent nucleotidase that exhibits a preference for UDP as a substrate. The enzyme's activity follows this order of preference: UDP > GDP > UTP > GTP. It exhibits very low activity towards ADP and even lower activity towards ATP. CANT1 does not hydrolyze AMP or GMP. This enzyme plays a significant role in proteoglycan synthesis.
Gene References Into Functions
  1. CANT1 long non-coding RNA demonstrates therapeutic efficacy by correcting aberrant long non-coding cascade in malignant uveal melanoma. PMID: 28330694
  2. The Multiple Epiphyseal Dysplasia (MED) phenotype is allelic to the more severe Desbuquois dysplasia phenotype, identifying CANT1 as a second locus for recessively inherited MED. PMID: 28742282
  3. A novel mutation in CANT1, c.467C>T (p.Ser156Phe), has been identified in three Indian patients with Desbuquois dysplasia, Kim type, from two families. PMID: 25486376
  4. Studies on proteoglycan synthesis in CANT1 mutated patient fibroblasts revealed significantly reduced GAG synthesis in the presence of beta-D-xyloside, suggesting a role for CANT1 in proteoglycan metabolism. PMID: 22539336
  5. Novel mutations in the CANT1 gene have been reported in three cases of Desbuquois dysplasia type I and fetal hydrops. PMID: 21654728
  6. The age of the founder mutation has been estimated to be approximately 1420 years. PMID: 21412251
  7. CANT1 is commonly overexpressed in a majority of primary prostate carcinomas and in the precursor lesion PIN, potentially serving as a novel prognostic biomarker. PMID: 21435463
  8. The clinical-radiographic spectrum produced by CANT1 mutations has been expanded to include Desbuquois dysplasia type 2 and Kim variant. PMID: 21037275
  9. This research involved the cloning, expression, and characterization of a human enzyme belonging to a new family of extracellular nucleotidases. PMID: 12234496
  10. The soluble apyrase is a calcium-binding protein, as evidenced by saturable Ca2+-dependent changes in intrinsic tryptophan fluorescence, UV difference absorption spectra, and Ca2+-triggered transition from enzymatically inactive form to active enzyme. PMID: 12600208
  11. The importance of the dimeric state for enzymatic activity and biological function in this nucleotidase was investigated by mutating isoleucine 170. PMID: 18067325
  12. Human soluble calcium-activated nucleotidase inhibits coagulation in vitro and thrombosis in vivo. PMID: 18222531
  13. The two novel ETV4 fusion partners share predominant common characteristics: androgen-induction and prostate-specific expression. PMID: 18451133
  14. Mutations in CANT1 have been identified as a cause of Desbuquois dysplasia. PMID: 19853239

Show More

Hide All

Database Links

HGNC: 19721

OMIM: 251450

KEGG: hsa:124583

STRING: 9606.ENSP00000307674

UniGene: Hs.8859

Involvement In Disease
Desbuquois dysplasia 1 (DBQD1); Epiphyseal dysplasia, multiple, 7 (EDM7)
Protein Families
Apyrase family
Subcellular Location
Endoplasmic reticulum membrane; Single-pass type II membrane protein. Golgi apparatus, Golgi stack membrane; Single-pass type II membrane protein. Cell membrane. Note=Processed form: Secreted.
Tissue Specificity
Widely expressed.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.